نوع مقاله : بیان دیدگاه
نویسندگان
1 استادیار، سیاست‌گذاری سلامت، مرکز تحقیقات مدیریت خدمات سلامت، پژوهشکده آینده‌پژوهی در سلامت، دانشگاه علوم پزشکی کرمان، کرمان، ایران
2 استادیار، سیاست‌گذاری سلامت، مرکز تحقیقات مدیریت و اقتصاد سلامت، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران
چکیده
-
عنوان مقاله [English]
Evidence Informed Policymaking in Infectious Disease Epidemics: Implications for Coronavirus Disease 2019 (COVID-19)
نویسندگان [English]
- Vahid Yazdi-Feyzabadi 1
- Mostafa Amini-Rarani 2
1 Assistant Professor, Health Policy, Health Services Management Research Center, Institute of Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
2 Assistant Professor, Health Policy, Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
چکیده [English]
The outbreak of emerging and acute infectious diseases is one of the threats to global health. Another such event is the latest global pandemic, coronavirus disease 2019 (COVID-19) COVID-19. The right policymaking and management of this pandemic require the use of scientific capabilities and evidence obtained from different experiences. However, as far as COVID-19 is a wicked problem, informed decision making for COVID-19 differs from policymaking in normal circumstances and faces difficulties. In general, we grouped these difficulties into three categories, including uncertainties, heterogeneous policymaking, and weaknesses of the history approach. Uncertainties of coronavirus can be resolved by the development of an integrated system for tracking deaths and mortality estimates, monitoring of the key characteristics of dead coronavirus patients and patients admitted to intensive care unit (ICU), as well as more work to assess the incidence and characteristics of coronavirus infections across the population. In order to minimize the harm caused by heterogeneous policies, it would be easier to clarify, interpret, and apply the macro-strategies of the World Health Organization (WHO) consistent with the local requirements of the country instead of not embracing and refusing them altogether. Furthermore, in order to make good use of the history-as lessons- approach of the epidemics in COVID-19 policy, the experiences of previous epidemics must be adequately clarified and logically interpreted and implemented in accordance with the temporal, environmental, and political circumstances of the COVID-19 epidemic.
- Smith J. Overcoming the ‘tyranny of the urgent’: Integrating gender into disease outbreak preparedness and response. Gend Dev 2019; 27(2): 355-69.
- Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc 2020; 83(3): 217-20.
- Zhang W, Qian BY. Making decisions to mitigate COVID-19 with limited knowledge. Lancet Infect Dis 2020.
- Poulos RG, Zwi AB, Lord SR. Towards enhancing national capacity for evidence informed policy and practice in falls management: A role for a "Translation Task Group"? Aust New Zealand Health Policy 2007; 4: 6.
- Banta HD. Considerations in defining evidence for public health: The European Advisory Committee on Health Research World Health Organization Regional Office for Europe. Int J Technol Assess Health Care 2003; 19(3): 559-72.
- Woodbury MG, Bscpt, Msc J, Kuhnke J. Evidence-based practice vs. evidence-informed practice: What's the difference? Wound Care Canada 2014; 12(1): 18-21.
- Lazzerini M, Putoto G. COVID-19 in Italy: Momentous decisions and many uncertainties. Lancet Glob Health 2020; 8(5): e641-e642.
- Moatti JP. The French response to COVID-19: Intrinsic difficulties at the interface of science, public health, and policy. Lancet Public Health 2020. [Epub ahead of print].
- Peckham R. COVID-19 and the anti-lessons of history. Lancet 2020; 395(10227): 850-2.
- Zarocostas J. How to fight an infodemic. Lancet 2020; 395(10225): 676.
)